Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v6.0)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-18

Query Trace: Hepatitis C and KIR2DL3[orginal query]

The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways. Tissue antigens 2015 Oct 86 (4): 267-75. Hydes T J, Moesker B, Traherne J A, Ashraf S, Alexander G J, Dimitrov B D, Woelk C H, Trowsdale J, Khakoo S Similar articles in PubMed
Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users. Journal of viral hepatitis 2014 Aug 21 (8): e65-73. Sugden P B, Cameron B, Luciani F, Lloyd A R, Similar articles in PubMed
KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C. Human immunology 2014 Aug 75 (8): 822-6. Umemura Takeji, Ota Masao, Katsuyama Yoshihiko, Wada Shuichi, Mori Hiromitsu, Maruyama Atsushi, Shibata Soichiro, Nozawa Yuichi, Kimura Takefumi, Morita Susumu, Joshita Satoru, Komatsu Michiharu, Matsumoto Akihiro, Kamijo Atsushi, Kobayashi Masakazu, Takamatsu Masato, Yoshizawa Kaname, Kiyosawa Kendo, Tanaka Ei Similar articles in PubMed
Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome. PloS one 2014 9 (6): e99426. Vidal-Castiñeira Jose Ramón, López-Vázquez Antonio, Martínez-Borra Jesús, Martínez-Camblor Pablo, Prieto Jesús, López-Rodríguez Rosario, Sanz-Cameno Paloma, de la Vega Juan, Rodrigo Luis, Pérez-López Rosa, Pérez-Álvarez Ramón, López-Larrea Carl Similar articles in PubMed
KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury. Transplantation 2013 Apr 95 (8): 1037-44. Legaz Isabel, López-Álvarez María R, Campillo José A, Moya-Quiles María R, Bolarín José M, de la Peña Jesus, Salgado Gema, Gimeno Lourdes, García-Alonso Ana M, Muro Manuel, Miras Manuel, Alonso Clara, Álvarez-López María R, Minguela Alfre Similar articles in PubMed
Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis C and responses to therapy in Brazil. Genetics and molecular biology 2013 Mar 36 (1): 22-7. de Vasconcelos Janaina Mota, de Jesus Maués Pereira Móia Lizomar, Amaral Ivanete do Socorro Abraçado, Miranda Esther Castello Branco Mello, Cicalisetakeshita Louise Yukari, de Oliveira Layanna Freitas, de Araújo Melo Mendes Lilian, Sastre Danuta, Tamegão-Lopes Bruna Pedroso, de Aquino Pedroza Larysse Santa Rosa, Batista Dos Santos Sidney Emanuel, Soares Manoel do Carmo Pereira, de Araújo Marialva Tereza Ferreira, Bandeira Camila Lucas, de Sousa da Silva Adriana Maria Paixão, de Medeiros Zilene Lameira, Sena Leonardo, Demachki Samia, Dos Santos Eduardo José Me Similar articles in PubMed
KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan. PloS one 2013 8 (12): e83381. Nozawa Yuichi, Umemura Takeji, Joshita Satoru, Katsuyama Yoshihiko, Shibata Soichiro, Kimura Takefumi, Morita Susumu, Komatsu Michiharu, Matsumoto Akihiro, Tanaka Eiji, Ota Mas Similar articles in PubMed
Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a. Journal of medical virology 2011 Oct 83 (10): 1733-7. Vejbaesya Sasijit, Nonnoi Yuwatida, Tanwandee Tawesak, Srinak Duangpo Similar articles in PubMed
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. PLoS medicine 2011 Sep 8 (9): e1001092. Suppiah Vijayaprakash, Gaudieri Silvana, Armstrong Nicola J, O'Connor Kate S, Berg Thomas, Weltman Martin, Abate Maria Lorena, Spengler Ulrich, Bassendine Margaret, Dore Gregory J, Irving William L, Powell Elizabeth, Hellard Margaret, Riordan Stephen, Matthews Gail, Sheridan David, Nattermann Jacob, Smedile Antonina, Müller Tobias, Hammond Emma, Dunn David, Negro Francesco, Bochud Pierre-Yves, Mallal Simon, Ahlenstiel Golo, Stewart Graeme J, George Jacob, Booth David R, Similar articles in PubMed
A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection. Gastroenterology 2011 Jul 141 (1): 320-5, 325.e1-2. Knapp Susanne, Warshow Usama, Ho K M Alexander, Hegazy Doha, Little Ann-Margaret, Fowell Andrew, Alexander Graeme, Thursz Mark, Cramp Matthew, Khakoo Salim Similar articles in PubMed
Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection. Immunobiology 2011 Jun 216 (6): 686-91. Granados-Montiel Julio, Zúñiga Joaquin, Azocar Jose, Feris Edmond J, Terreros Daniel, Larsen Charles E, Clavijo Olga P, Cruz-Lagunas Alfredo, Middleton Derek, Alper Chester A, Pandey Janardan P, Yunis Edmond Similar articles in PubMed
Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology (Baltimore, Md.) 2010 Apr 51 (4): 1168-75. Knapp Susanne, Warshow Usama, Hegazy Doha, Brackenbury Louise, Guha I Neil, Fowell Andrew, Little Ann-Margaret, Alexander Graeme J, Rosenberg William M C, Cramp Matthew E, Khakoo Salim Similar articles in PubMed
Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. Journal of virology 2010 Jan 84 (1): 475-81. Vidal-Castiñeira J R, López-Vázquez A, Díaz-Peña R, Alonso-Arias R, Martínez-Borra J, Pérez R, Fernández-Suárez J, Melón S, Prieto J, Rodrigo L, López-Larrea Similar articles in PubMed
Protective KIR-HLA interactions for HCV infection in intravenous drug users. Molecular immunology 2009 Aug 46 (13): 2723-7. Zúñiga Joaquín, Romero Viviana, Azocar José, Terreros Daniel, Vargas-Rojas María Inés, Torres-García Diana, Jiménez-Alvarez Luis, Vargas-Alarcón Gilberto, Granados-Montiel Julio, Husain Zaheed, Chung Raymond T, Alper Chester A, Yunis Edmond Similar articles in PubMed
Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009 Apr 15 (4): 4. de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F Similar articles in PubMed
Natural killer cells and immune surveillance. Jornal de pediatria 2008 Aug 84 (4 Suppl): S58-67. Jobim Mariana, Jobim Luiz F Similar articles in PubMed
Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Molecular immunology 2008 May 45 (9): 2429-36. Romero Viviana, Azocar Jose, Zúñiga Joaquin, Clavijo Olga P, Terreros Daniel, Gu Xiangjun, Husain Zaheed, Chung Raymond T, Amos Christopher, Yunis Edmond Similar articles in PubMed
HLA-C and KIR genes in hepatitis C virus infection. Human immunology 2005 Nov 66 (11): 1106-9. Montes-Cano Marco Antonio, Caro-Oleas José Luis, Romero-Gómez Manuel, Diago Moisés, Andrade Raul, Carmona Isabel, Aguilar Reina José, Núñez-Roldán Antonio, González-Escribano María Francis Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Jul 30, 2019
Page last updated:Oct 31, 2019
Content source:

TOP